Clinical Study of 68Ga Labeled HER2 Affibody Analogues

NCT05411432 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

56

Enrollment

OTHER

Sponsor class

Conditions

HER2-positive Breast Cancer and Gastric Cancer

Interventions

DRUG: 68Ga labeled HER2 Affibody

Sponsor

Xijing Hospital